BioCentury
ARTICLE | Financial News

Hyperion planning $50 million follow-on

February 28, 2013 2:08 AM UTC

Hyperion Therapeutics Inc. (NASDAQ:HPTX) said it plans to raise up to $50 million in a follow-on underwritten by Leerink; Cowen; Needham; and JMP Securities. FDA approved Hyperion's Ravicti glycerol p...